PAR 0.00% 23.5¢ paradigm biopharmaceuticals limited..

Pre approval marketing has begun., page-27

  1. 345 Posts.
    lightbulb Created with Sketch. 200
    Nope.
    From what I can gather, Par are still not releasing Zilosul for Special Access Scheme if purpose is for OA
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.